Guardion Health Sciences Inc (GHSI) Actualités

Form 8-K - Current report

Guardion Health Sciences Announces Filing of Certificate of Dissolution

HOUSTON, TEXAS, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion”...

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities

Form 8-K - Current report

 Guardion Health Sciences Announces Adoption of Plan of Dissolution and Liquidation; Appointment of Interim President and CEO

Plan includes Voluntary Delisting of Common Stock from Nasdaq and Suspension of SEC Reporting Obligations...

Form 8-K - Current report

Form 8-K - Current report

Guardion Health Sciences Declares Cash Dividend of $5.00 Per Share of Common Stock

HOUSTON, TEXAS, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion”...

Form 8-K - Current report

Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2024

Guardion Also Provides an Update to Stockholders of Significant Recent Developments HOUSTON, TEXAS, Aug. 13...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 8-K - Current report

Guardion Health Sciences Announces Completion of Sale of its Viactiv® Brand and Business to Doctor’s Best Inc. and Stockholder Approval of Plan of Liquidation and Dissolution

HOUSTON, TEXAS, May 31, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material